Icecure Medical is trading 7.69% up at $2.80, mainly reflecting healthcare-sector strength following positive cancer-vaccine trial news.
- It closed at $2.60 on August 18, 2026.
- No fresh company-specific announcement has been identified for August 19.
- Latest reported developments, including first-half revenue growth and a board change, predate today’s move.